Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
25,299,931
-
Share change
-
+2,024,916
-
Total reported value
-
$49,329,000
-
Price per share
-
$1.95
-
Number of holders
-
51
-
Value change
-
+$4,787,402
-
Number of buys
-
23
-
Number of sells
-
18
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2017
As of 31 Mar 2017,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,299,931 shares.
The largest 10 holders included
Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, venBio Select Advisor LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Candriam Luxembourg S.C.A., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and Knott David M.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.